Skip to main content

Advertisement

Log in

Bisphosphonate Delivery to Tubular Bone Allografts

  • Symposium: New Approaches to Allograft Transplantation
  • Published:
Clinical Orthopaedics and Related Research

Abstract

Large structural allografts used for reconstruction of bone defects after revision arthroplasty and tumor resection fracture up to 27% of the time from osteolytic resorption around the fixation screw holes and tendon or ligament attachment sites. Treating structural allografts before implantation with bisphosphonates may inhibit local osteoclastic processes and prevent bone resorption and the development of stress risers, thereby reducing the long-term fracture rate. Taking advantage of allografts’ open-pore structure, we asked whether passive soaking or positive-pressure pumping was a more efficient technique for delivering bisphosphonates. We treated matched pairs of ovine tibial allografts with fluids containing Tc-99m pamidronate and toluidine blue stain to facilitate indicator distribution analysis via microSPECT-microCT imaging and light microscopy, respectively. Surfactants octylphenoxy polyethoxy ethanol or beractant were added to the treatment fluids to reduce flow resistance of solutions pumped through the allografts. Indicator distribution after 1 hour of soaking produced a thin ring around periosteal and endosteal surfaces, while pumping for 10 minutes produced a more even distribution throughout the allograft. Flow resistance was reduced with octylphenoxy polyethoxy ethanol but unaffected with beractant. Pumped allografts displayed a more homogeneous indicator distribution in less time than soaking while surfactants enhanced fluid movement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1A–B
Fig. 2
Fig. 3A–B
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Aspenberg P, Astrand J. Bone allografts pretreated with a bisphosphonate are not resorbed. Acta Orthop Scand. 2002;73:20–23.

    Article  PubMed  Google Scholar 

  2. Berrey B, Lord C, Gebhardt M, Mankin H. Fractures of allografts, frequency, treatment, and end-results. J Bone Joint Surg Am. 1990;72:825–833.

    PubMed  Google Scholar 

  3. Brigman B, Hornicek F, Gebhardt M, Mankin H. Allografts about the knee in young patients with high-grade sarcoma. Clin Orthop Relat Res. 2004;421:232–239.

    Article  PubMed  Google Scholar 

  4. Donati D, Di Bella C. In vivo study on critical defects using the sheep model. Chir Organi Mov. 2005;90:31–39.

    PubMed  CAS  Google Scholar 

  5. Enders A, Knight R. Incorporating pore geometry and fluid pressure communication into modeling the elastic behavior of porous rocks. Geophysics. 1997;62:106–117.

    Article  Google Scholar 

  6. Foster WR. Low-tension waterflooding process. J Petrol Tech. 1973:25:205–210.

    CAS  Google Scholar 

  7. Fox E, Hau M, Gebhardt M, Hornicek FJ, Tomford WW, Mankin HJ. Long-term followup of proximal femoral allografts. Clin Orthop Relat Res. 2002;97:106–113.

    Article  Google Scholar 

  8. Frenkel S, Jaffe WL, Valle CD, Jazrawi L, Maurer S, Baitner A, Wright K, Sala D, Hawkins M, Di Cesare PE. The effect of alendronate (fosamax) and implant surface on bone integration and remodeling in a canine model. J Biomed Mater Res. 2001;58:645–650.

    Article  PubMed  CAS  Google Scholar 

  9. Friedlander G. Current concepts review bone-banking. J Bone Joint Surg Am. 1982;64:307–311.

    Google Scholar 

  10. Hortobagyi GN, Theriault RL, Lipton A, Porter L, Blayney D, Sinoff C, Wheeler H, Simeone JF, Seaman JJ, Knight RD, Heffernan M, Mellars K, Reitsma DJ. Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group. J Clin Oncol. 1998;16:2038–2044.

    PubMed  CAS  Google Scholar 

  11. Hortobagyi GN, Theriault RL, Porter L, Blayney D, Lipton A, Sinoff C, Wheeler H, Simeone JF, Seaman J, Knight RD. Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 Aredia Breast Cancer Study Group. N Engl J Med. 1996;335:1785–1791.

    Article  PubMed  CAS  Google Scholar 

  12. Hui M, Blunt M. Effects of wettability on three-phase flow in porous media. J Phys Chem B. 2000;104:3833–3845.

    Article  CAS  Google Scholar 

  13. Jakobsen T, Baas J, Bechtold JE, Elmengaard B, Saballe K. Soaking morselized allograft in bisphosphonate can impair implant fixation. Clin Orthop Relat Res. 2007;463:195–201.

    PubMed  Google Scholar 

  14. Jung A, Bisaz S, Fleisch H. The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals. Calc Tiss Res. 1973;11:269–280.

    Article  CAS  Google Scholar 

  15. Kainer M, Linden J, Whaley D, Holmes HT, Jarvis WR, Jernigan DB, Archibald LK. Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med. 2004;350:2564–2571.

    Article  PubMed  CAS  Google Scholar 

  16. Kumar D, Kumar V, Little DG, Howman-Giles RB, Wong E, Ali SO. Evaluation of biodistribution by local versus systemic administration of 99mTc-labeled pamidronate. J Orthop Sci. 2006;11:512–520.

    Article  PubMed  CAS  Google Scholar 

  17. Leitman S, Tomford W, Gebhardt M, Springfield D, Mankin H. Complications of irradiated allografts in orthopaedic tumor surgery. Clin Orthop Relat Res. 2000;375:214–217.

    Article  Google Scholar 

  18. Lin J. Bisphosphonates: a review of their pharmocokinetic properties. Bone. 1996;18:75–85.

    Article  PubMed  CAS  Google Scholar 

  19. Lipton A, Theriault RL, Hortobagyi GN, Simeone J, Knight RD, Mellars K, Reitsma DJ, Heffernan M, Seaman JJ. Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials. Cancer. 2000;88:1082–1090.

    Article  PubMed  CAS  Google Scholar 

  20. Mankin H, Doppelt S, Tomford W. Clinical experience with allograft implantation. The first ten years. Clin Orthop Relat Res. 1983;174:69–86.

    PubMed  Google Scholar 

  21. Martin B. Porosity and specific surface of bone. Crit Rev Biomed Eng. 1984;10:179–222.

    PubMed  CAS  Google Scholar 

  22. Rosenquist JB, Baylink DJ. Resorption of bone implants. Int J Oral Surg. 1978;7:7–10.

    Article  PubMed  CAS  Google Scholar 

  23. Russell RG, Rogers MJ, Frith JC, Luckman SP, Coxon FP, Benford HL, Croucher PI, Shipman C, Fleisch HA. The pharmacology of bisphosphonates and new insights into their mechanisms of action. J Bone Miner Res. 1999;14 Suppl 2:53–65.

    PubMed  CAS  Google Scholar 

  24. Sorger JI, Hornicek FJ, Zavatta M, Menzner JP, Gebhardt MC, Tomford WW, Mankin HJ. Allografts fractures revisited. Clin Orthop Relat Res. 2001;382:66–74.

    Article  PubMed  Google Scholar 

  25. Theriault RL, Lipton A, Hortobagyi GN, Leff R, Glück S, Stewart JF, Costello S, Kennedy I, Simeone J, Seaman JJ, Knight RD, Mellars K, Heffernan M, Reitsma DJ. Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. J Clin Oncol. 1999;17:846–854.

    PubMed  CAS  Google Scholar 

  26. Tomford W, Doppelt S, Mankin H, Friedlander G. 1983 Bone Bank Procedures. Clin Orthop Relat Res. 1983;174:15–21.

    PubMed  Google Scholar 

  27. Wu N, Dai J, Micale FJ. Dynamic surface tension measurement with a dynamic Wilhelmy plate technique J. Colloid Interface Sci. 1999;215:258–269.

    Article  CAS  Google Scholar 

  28. Zar H. Comparing simple linear regression equations. In: Zar JH. Biostatistical Analysis, 4th ed. Prentice-Hall: Upper Saddle River, NJ; 1999:360–376.

    Google Scholar 

Download references

Acknowledgments

We thank Abbott Laboratories for donating the beractant (Survanta®), and Colorado State University College of Veterinary Medicine for donating the ovine sheep tibia.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gene R. DiResta PhD.

Additional information

One or more of the authors (CM, JHH) has received funding from the Orthopaedic Research and Education Foundation; the Musculoskeletal Transplant Foundation; and the Biomet Oncology Fellowship. We acknowledge technical services provided by the MSKCC Small-Animal Imaging Core Facility, supported in part by NIH Small Animal Imaging Research Program (SAIRP) grant #R24 CA83084 and NIH Center Grant #P30 CA 08748.

Each author certifies that his or her institution has approved the animal protocol for this investigation and that all investigations were conducted in conformity with ethical principles of research.

About this article

Cite this article

DiResta, G.R., Manoso, M.W., Naqvi, A. et al. Bisphosphonate Delivery to Tubular Bone Allografts. Clin Orthop Relat Res 466, 1871–1879 (2008). https://doi.org/10.1007/s11999-008-0259-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11999-008-0259-7

Keywords

Navigation